CALL - SPRINTER OPEN END - MERCK & CO. Share Price

Certificat

DE000VM7XBC9

Real-time Boerse Frankfurt Warrants 09:14:43 03/07/2024 BST
1.36 EUR +7.09% Intraday chart for CALL - SPRINTER OPEN END - MERCK & CO.
Current month-9.93%
1 month+14.41%
Date Price Change
03/07/24 1.36 +7.09%
02/07/24 1.27 -4.51%
01/07/24 1.33 -5.67%
28/06/24 1.41 -0.70%
27/06/24 1.42 -20.67%

Real-time Boerse Frankfurt Warrants

Last update July 03, 2024 at 09:14 am

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM7XBC
ISINDE000VM7XBC9
Date issued 03/01/2024
Strike 114.1 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.28
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.93
Lowest since issue 0.39
Spread 0.08
Spread %5.63%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
127.7 USD
Average target price
142.7 USD
Spread / Average Target
+11.71%
Consensus